- Home
- PAX vs VCYT Comparison
PAX vs VCYT Comparison
Compare PAX & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAX
- VCYT
- Stock Information
- Founded
- PAX 1988
- VCYT 2006
- Country
- PAX Cayman Islands
- VCYT United States
- Employees
- PAX N/A
- VCYT N/A
- Industry
- PAX Investment Managers
- VCYT Medical Specialities
- Sector
- PAX Finance
- VCYT Health Care
- Exchange
- PAX Nasdaq
- VCYT Nasdaq
- Market Cap
- PAX 2.1B
- VCYT 2.1B
- IPO Year
- PAX 2021
- VCYT 2013
- Fundamental
- Price
- PAX $13.76
- VCYT $30.22
- Analyst Decision
- PAX Strong Buy
- VCYT Buy
- Analyst Count
- PAX 1
- VCYT 9
- Target Price
- PAX $14.00
- VCYT $39.89
- AVG Volume (30 Days)
- PAX 436.1K
- VCYT 2.4M
- Earning Date
- PAX 08-01-2025
- VCYT 08-06-2025
- Dividend Yield
- PAX 6.34%
- VCYT N/A
- EPS Growth
- PAX N/A
- VCYT N/A
- EPS
- PAX 0.53
- VCYT 0.34
- Revenue
- PAX $397,504,000.00
- VCYT $479,129,000.00
- Revenue This Year
- PAX $4.76
- VCYT $12.57
- Revenue Next Year
- PAX $4.18
- VCYT $10.23
- P/E Ratio
- PAX $26.11
- VCYT $90.02
- Revenue Growth
- PAX 26.52
- VCYT 19.91
- 52 Week Low
- PAX $9.43
- VCYT $22.61
- 52 Week High
- PAX $14.52
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- PAX 50.71
- VCYT 67.14
- Support Level
- PAX $13.45
- VCYT $26.61
- Resistance Level
- PAX $14.03
- VCYT $30.73
- Average True Range (ATR)
- PAX 0.32
- VCYT 1.17
- MACD
- PAX -0.01
- VCYT 0.75
- Stochastic Oscillator
- PAX 68.35
- VCYT 93.47
About PAX Patria Investments Limited
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.